| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
55,773 |
48,922 |
$3.14M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,487 |
31,783 |
$2.82M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12,597 |
12,064 |
$920K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,749 |
9,003 |
$646K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
7,977 |
7,658 |
$574K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16,583 |
15,595 |
$396K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
33,206 |
26,339 |
$386K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23,942 |
22,543 |
$330K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,193 |
3,056 |
$254K |
| 92551 |
|
18,182 |
17,332 |
$183K |
| 87428 |
|
4,123 |
3,812 |
$146K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,136 |
775 |
$111K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,831 |
2,643 |
$97K |
| 99188 |
|
5,225 |
4,991 |
$96K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,783 |
2,696 |
$93K |
| 99173 |
|
17,823 |
16,986 |
$80K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,138 |
4,767 |
$78K |
| 99381 |
|
940 |
862 |
$66K |
| 94760 |
|
18,996 |
16,654 |
$66K |
| 99383 |
|
590 |
572 |
$45K |
| 90473 |
|
3,691 |
3,458 |
$42K |
| 90686 |
|
8,752 |
8,184 |
$38K |
| 96127 |
|
8,692 |
6,995 |
$38K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,076 |
965 |
$38K |
| 90791 |
Psychiatric diagnostic evaluation |
300 |
294 |
$35K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
951 |
893 |
$34K |
| 83655 |
|
2,901 |
2,795 |
$34K |
| 99215 |
Prolong outpt/office vis |
277 |
245 |
$33K |
| 87807 |
|
2,543 |
2,368 |
$29K |
| 96161 |
|
5,245 |
4,710 |
$25K |
| 99174 |
|
6,512 |
6,196 |
$25K |
| 99382 |
|
324 |
304 |
$24K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,129 |
772 |
$23K |
| 99384 |
|
218 |
206 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
204 |
196 |
$15K |
| 90670 |
|
5,900 |
5,524 |
$15K |
| 90648 |
|
6,525 |
6,125 |
$13K |
| 83718 |
|
1,481 |
1,390 |
$11K |
| 96160 |
|
4,493 |
4,278 |
$11K |
| 96112 |
|
124 |
119 |
$10K |
| 0071A |
|
288 |
251 |
$10K |
| 0072A |
|
194 |
180 |
$7K |
| 85018 |
|
2,925 |
2,788 |
$7K |
| 82465 |
|
1,467 |
1,379 |
$7K |
| 36416 |
|
3,166 |
3,022 |
$6K |
| 90723 |
|
3,880 |
3,601 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
45 |
41 |
$4K |
| 96113 |
|
63 |
59 |
$4K |
| 81002 |
|
1,948 |
1,783 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
580 |
528 |
$4K |
| 81025 |
|
493 |
465 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
404 |
270 |
$4K |
| 99401 |
|
65 |
63 |
$3K |
| 90633 |
|
3,567 |
3,369 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
49 |
39 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
196 |
180 |
$3K |
| 96380 |
|
188 |
137 |
$2K |
| 0073A |
|
38 |
38 |
$2K |
| 0081A |
|
33 |
27 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
14 |
12 |
$997.87 |
| 90698 |
|
50 |
44 |
$966.12 |
| 90681 |
|
1,983 |
1,820 |
$920.20 |
| 90651 |
|
1,897 |
1,792 |
$835.46 |
| 90734 |
|
1,663 |
1,574 |
$817.06 |
| 94664 |
|
77 |
72 |
$786.90 |
| 90710 |
|
3,269 |
3,105 |
$595.57 |
| 90680 |
|
965 |
930 |
$547.13 |
| 0154A |
|
18 |
12 |
$526.00 |
| 90672 |
|
631 |
586 |
$509.47 |
| 0111A |
|
14 |
12 |
$486.00 |
| 0112A |
|
13 |
12 |
$486.00 |
| 0001A |
|
13 |
13 |
$480.00 |
| 99072 |
|
3,566 |
3,095 |
$468.67 |
| 90715 |
|
1,137 |
1,076 |
$324.97 |
| 90656 |
|
1,003 |
983 |
$211.77 |
| 94761 |
|
69 |
62 |
$137.12 |
| 82947 |
|
44 |
39 |
$103.44 |
| 90685 |
|
16 |
12 |
$94.32 |
| 86308 |
|
14 |
13 |
$62.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
64 |
25 |
$46.77 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
66 |
61 |
$0.18 |
| 90700 |
|
1,569 |
1,499 |
$0.00 |
| 90671 |
|
1,735 |
1,652 |
$0.00 |
| 91311 |
|
40 |
34 |
$0.00 |
| 91300 |
|
94 |
82 |
$0.00 |
| 99051 |
|
26 |
26 |
$0.00 |
| 91308 |
|
72 |
56 |
$0.00 |
| 90380 |
|
54 |
30 |
$0.00 |
| 90696 |
|
1,597 |
1,501 |
$0.00 |
| 90697 |
|
782 |
730 |
$0.00 |
| 90620 |
|
110 |
105 |
$0.00 |
| 99000 |
|
587 |
552 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
67 |
64 |
$0.00 |
| 91307 |
|
642 |
530 |
$0.00 |
| 90381 |
|
80 |
55 |
$0.00 |
| 91315 |
|
13 |
12 |
$0.00 |